Hainan Shuangcheng Pharmaceuticals announcement: The company is planning a major asset restructuring, intending to acquire 100% of the shares of Ningbo Aura Semiconductor Co., Ltd. through the issuance of shares and payment of cash, and intends to issue shares to no more than 35 specific investors to raise matching funds. As of the disclosure date of this announcement, the audit and evaluation of the target assets have not been completed, and the specific transaction price of this transaction has not been determined. Considering that the current semiconductor index (886063.WI) has significantly declined from its peak in 2021, the global macroeconomic environment and the investment and financing environment of the semiconductor industry have changed compared to 2021. In this transaction, the company plans to engage an evaluation institution that complies with legal regulations to evaluate the equity value of the target company, and this evaluation will use two methods: the cost approach, the income approach, and will refer to trading cases in the semiconductor industry. As a result, the valuation of the target company in this transaction will be significantly lower than the valuation of the previous financing, 10 billion yuan.